ProMIS Neurosciences
OrganisationROR
Develops
PMN310
Trials
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
Phase 1Active, not recruiting2024144 people27 Dec 2024clinicaltrials.gov
Competes in
28 Sept 2026promisneurosciences.com
OrganisationROR
PMN310
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
Phase 1Active, not recruiting2024144 people27 Dec 2024clinicaltrials.gov
28 Sept 2026promisneurosciences.com